Trial Condition(s):
Mirena efficiency and tolerability during the first year of use
In this trial the efficacy and safety of Mirena was investigated during the first year of use
- Women aged 25 to 39 years who sought effective contraception during the post-partum period (i.e. insertion of the device between 6 and 12 weeks after parturition).
- Standard exclusion criteria for use of intrauterine hormone devices
Locations | Status | ||
---|---|---|---|
Locations Centre de Gynecologie Obstetrique Amiens Cedex 01, France, 80054 | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |
A multicentre, open label, uncontrolled study of the tolerance, acceptability and contraceptive efficacy of Mirena 52 mg®, an intra-uterine levonorgestrel device, during the first year after insertion post-partum
Trial Type:
Interventional
Intervention Type:
Drug
Trial Purpose:
Treatment
Allocation:
Non-randomized
Blinding:
Open Label
Assignment:
Single Group Assignment
Trial Arms:
1